Patent · US Active

Enhanced delivery epinephrine compositions

US11191737B2 · kind B2 · utility

2Cited by
455References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2017
Grant dateDec 7, 2021
Priority date—
Expiry dateMay 4, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical compositions having enhanced active component permeation properties are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.